Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TAPO in first-line osimertinib therapy and continuation of osimertinib.
Mimura C, Kaneshiro K, Fujimoto S, Dokuni R, Iwamoto N, Matsumura K, Hatakeyama Y, Kono Y, Tachihara M. Mimura C, et al. Among authors: hatakeyama y. Thorac Cancer. 2023 Feb;14(6):584-591. doi: 10.1111/1759-7714.14782. Epub 2022 Dec 28. Thorac Cancer. 2023. PMID: 36578073 Free PMC article.
Bronchoscopy Using Virtual Navigation and Endobronchial Ultrasonography with a Guide Sheath (EBUS-GS) with or without Fluoroscopy for Peripheral Pulmonary Lesions.
Tachihara M, Tamura D, Kiriu T, Tokunaga S, Hatakeyama Y, Shinke H, Nagano T, Nakata K, Hazeki N, Kamiryo H, Kobayashi K, Nishimura Y. Tachihara M, et al. Among authors: hatakeyama y. Kobe J Med Sci. 2018 Mar 27;63(4):E99-E104. Kobe J Med Sci. 2018. PMID: 29955020 Free PMC article. Clinical Trial.
Endobronchial metastases 20 years after prostate cancer excision.
Hatakeyama Y, Yoshimura S, Ninomaru T, Fujimoto S, Takamiya R, Okamura K, Sano N, Ohnishi H. Hatakeyama Y, et al. Respir Med Case Rep. 2019 May 20;27:100858. doi: 10.1016/j.rmcr.2019.100858. eCollection 2019. Respir Med Case Rep. 2019. PMID: 31193720 Free PMC article.
A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
Tachihara M, Kiriu T, Hata A, Hatakeyama Y, Nakata K, Nagano T, Yamamoto M, Kobayashi K, Ohnishi H, Katakami N, Nishimura Y. Tachihara M, et al. Among authors: hatakeyama y. Cancer Manag Res. 2019 Jul 29;11:7135-7140. doi: 10.2147/CMAR.S208224. eCollection 2019. Cancer Manag Res. 2019. PMID: 31534366 Free PMC article.
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC.
Katsurada N, Tachihara M, Hatakeyama Y, Koyama K, Yumura M, Kiriu T, Dokuni R, Hazama D, Tokunaga S, Tamura D, Nakata K, Yamamoto M, Kamiryo H, Kobayashi K, Tanaka Y, Maniwa Y, Nishimura Y. Katsurada N, et al. Among authors: hatakeyama y. Cancer Manag Res. 2020 Feb 3;12:777-782. doi: 10.2147/CMAR.S239647. eCollection 2020. Cancer Manag Res. 2020. PMID: 32099473 Free PMC article.
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer.
Fukuda K, Katsurada N, Kawa Y, Satouchi M, Kaneshiro K, Matsumoto M, Takamiya R, Hatakeyama Y, Dokuni R, Matsumura K, Katsurada M, Nakata K, Yoshimura S, Tachihara M. Fukuda K, et al. Among authors: hatakeyama y. Heliyon. 2023 Sep 26;9(10):e20463. doi: 10.1016/j.heliyon.2023.e20463. eCollection 2023 Oct. Heliyon. 2023. PMID: 37822623 Free PMC article.
A metabolomic approach to lung cancer.
Hori S, Nishiumi S, Kobayashi K, Shinohara M, Hatakeyama Y, Kotani Y, Hatano N, Maniwa Y, Nishio W, Bamba T, Fukusaki E, Azuma T, Takenawa T, Nishimura Y, Yoshida M. Hori S, et al. Among authors: hatakeyama y. Lung Cancer. 2011 Nov;74(2):284-92. doi: 10.1016/j.lungcan.2011.02.008. Epub 2011 Mar 15. Lung Cancer. 2011. PMID: 21411176
293 results